Tandem Insulin Pump Recall - Czech Language User Guide Translation Errors
Summary
FDA initiated a Class II recall (Z-1636-2026) of Tandem Diabetes Care insulin pumps due to translation errors in Czech language user guides distributed in Czech Republic and Slovakia. The critical error instructed users to verify the infusion set IS connected to the body when users should confirm it is NOT connected. The recall is ongoing as of April 1, 2026.
What changed
Tandem Diabetes Care initiated a Class II medical device recall affecting battery-operated insulin infusion pumps distributed internationally in Czech Republic and Slovakia. The Czech language user guide contained translation errors, the most significant being incorrect instructions for verifying infusion set connection status. Users were directed to confirm the set IS connected when the correct instruction should direct users to confirm it is NOT connected.
Medical device manufacturers and distributors with affected products should verify their inventory for Czech/Slovak language user guides and coordinate with Tandem Diabetes Care for corrected documentation. Healthcare providers treating patients using these devices should confirm patients have received accurate user guides. The recall remains ongoing with no specific return deadline provided.
What to do next
- Verify inventory for affected insulin pump user guides in Czech/Slovak languages
- Contact Tandem Diabetes Care to obtain corrected user guides
- Notify affected patients and healthcare providers of the translation error and provide updated materials
Source document (simplified)
Tandem Diabetes Care, Inc.
Device Recalls (Class II)
← All Device Recalls (Class II) Class II Z-1636-2026 · 20260401 · Ongoing
Product
Tandem pumps are battery-operated infusion pumps capable of both basal and bolus delivery of insulin. The pumps utilize a motor-driven mechanism to deliver insulin from within a disposable cartridg...
Reason for Recall
The Czech language user guide contained multiple translation errors. The most significant error was that it incorrectly instructs users to verify that the infusion set is connected to the body, when it should instead direct users to confirm that the infusion set is not connected to the body. Fol...
Distribution
International distribution in the countries of Czech Republic, Slovakia.
Source: openFDA Enforcement API
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when FDA: Device Recalls Class II publishes new changes.